Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10

Treatment Description

Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10 is a monoclonal antibody that is designed to deliver cytotoxic radiation to cancer cells. It is being studied for use in several different indications.

Participating Centers

There is one center running trials with this treatment. Enter a location below to view the distance.